Cite
Phenotype Standardization for Statin-Induced Myotoxicity
MLA
Sub Pharmacotherapy, Theoretical, et al. Phenotype Standardization for Statin-Induced Myotoxicity. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1416069303&authtype=sso&custid=ns315887.
APA
Sub Pharmacotherapy, T., Pharmacoepidemiology and Clinical Pharmacology, Alfirevic, A., Neely, D., Armitage, J., Chinoy, H., Cooper, R. G., Laaksonen, R., Carr, D. F., Bloch, K. M., Fahy, J., Hanson, A., Yue, Q. Y., Wadelius, M., Maitland-van Der Zee, A. H., Voora, D., Psaty, B. M., Palmer, C. N. A., & Pirmohamed, M. (2014). Phenotype Standardization for Statin-Induced Myotoxicity.
Chicago
Sub Pharmacotherapy, Theoretical, Pharmacoepidemiology and Clinical Pharmacology, A. Alfirevic, D. Neely, J. Armitage, H. Chinoy, R. G. Cooper, et al. 2014. “Phenotype Standardization for Statin-Induced Myotoxicity.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1416069303&authtype=sso&custid=ns315887.